WebApr 6, 2024 · A high-level overview of Titan Pharmaceuticals, Inc. (TTNP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebTTNP's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. Home Guide ... Helpful articles on different dividend investing options and how to best …
Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Price
WebCompany Overview. Titan is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides the potential for an efficacy and/or safety benefit. Titan's lead product in development is an implant ... WebView the TTNP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Titan Pharmaceuticals Inc real time stock … onn wy133a características
Titan Pharmaceuticals Inc Stock Options (TTNP) - Investing.com PH
WebMar 18, 2024 · Titan Pharmaceuticals stock was originally listed at a price of $5,593.81 in Dec 31, 1997. If you had invested in Titan Pharmaceuticals stock at $5,593.81, your return over the last 25 years would have been -99.99%, for an annualized return of -29.89% (not including any dividends or dividend reinvestments). WebGet free option chain data for TTNP. Find Call and Put Strike Prices, Last Price, Change, Volume, and more for Titan Pharma share options. WebApr 3, 2024 · Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and … onn wireless neckband earphones